Areas of Interest

• Major Depressive Disorder (MDD) journey to Treatment Resistant Depression (TRD)
• TRD: definition, early patient identification & characteristics, timely diagnosis & treatment initiation
• Advancing current treatment paradigms in TRD
• Mechanistic rationale to treatment approaches
• Innovation & pharmacological trends in disease management including interventional psychiatry treatments
• Disease burden and overcoming treatment access challenges
• Impact MDD & TRD in minoritized communities and populations
  • Emphasis on the current mental health crisis
• NP & PA’s role in the disease management of TRD

Areas of Interest

• Transition from an oral antipsychotic to a long-acting injectable (LAI) antipsychotic
• Atypical antipsychotic LAIs for adults with schizophrenia – Focus on early use psychosis clinics (clinical and psychosocial outcomes)
• Patterns of atypical antipsychotic LAI utilization in minoritized communities and populations (including social determinants of health)
  • Emphasis on the current mental health crisis
• Effects and dynamics of the treatment coalition in adopting atypical antipsychotic LAI utilization earlier in schizophrenia treatment journey
• Competency models assessing injection techniques in the administration of atypical antipsychotic LAIs
• Antipsychotic LAI transition of care models (inpatient to outpatient)

• Nurse Practitioners
• Early-in-Career
• Psychiatrists
• Patient
• Caregiver / Care Team
• Physician Assistants
• Pharmacists

Please click here to view the certificate of separation

Click here to submit an Independent Medical Education Grant